What has been measured for NAD+ precursors in dogs?

The short answer

Answered from published research literature only. It describes what that literature examines; it is not a statement about use in people. NAD+ is investigational research material and is not an approved product.

A randomised placebo-controlled trial in senior dogs reported owner-assessed cognitive outcomes for a combination product, and separate work examined NAD+ content in a canine muscular-dystrophy model.3881163438044436

Cited literature

1. A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination.Sci Rep · 2024PMID 38811634 ↗
2. Replenishing NAD+ content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy.Skelet Muscle · 2023PMID 38044436 ↗

Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.

Where to read more

• NAD+: identity and cited literature
• NAD+ product page
• NAD+ certificate of analysis
• NAD+: the canine, equine literature, with its caveats